Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9429203 | Neuroscience Letters | 2005 | 4 Pages |
Abstract
Excess cholesterol is removed from the brain via hydroxylation mediated by cholesterol 24S-hydroxylase (CYP46). Although serum and cerebrospinal fluid (CSF) concentrations of 24S-hydroxycholesterol are altered during the progress of Alzheimer's disease, studies carried out to date in different populations on the association of CYP46 gene polymorphisms and risk of AD have been inconclusive. In this report, we analyzed CYP46 polymorphisms in 215 Polish AD cases and 173 healthy individuals. A fragment of CYP46 intron 2 was amplified by PCR reaction and sequenced. We discovered a new single nucleotide substitution in CYP46 intron 2, but found no difference in particular genotype or allele frequencies between AD patients and controls. However, the GG genotype of the known rs754203 polymorphic site might be a risk factor for AD, especially in APOE É4 carriers. Interestingly, in AD patients the rs754203 G allele was more frequent in males than in females. However, considering the extreme divergence of results obtained by different authors, a clear connection between the CYP46 gene and AD is questionable.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Ewa Golanska, Krystyna Hulas-Bigoszewska, Izabela Wojcik, Piotr Rieske, Maria Styczynska, Beata Peplonska, Anna Pfeffer, Elzbieta Luczywek, Boguslaw Wasiak, Tomasz Gabryelewicz, Dorota Religa, Malgorzata Chodakowska-Zebrowska, Maria Barcikowska,